More from Renaissance Capital

Singulex files for a $86 million IPO

By Renaissance Capital,  September 28, 2012, 06:00:36 PM EDT

Singulex, which develops innovative tests for the diagnosis and monitoring of chronic diseases, filed on Friday with the SEC to raise up to $86 million in an initial public offering. The Alameda, CA-based company, which was founded in 1997 and booked $38 million in sales for the 12 months ended 6/30/2012, plans to list on the NYSE under the symbol SGLX. UBS Investment Bank and Piper Jaffray are the joint bookrunners on the deal. No pricing terms were disclosed.




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.


This article appears in: News Headlines, IPOs

Referenced Stocks:



Latest News Video

Twitter Rolls Out Two-Step Verification to Curb Hacking
Twitter Rolls Out Two-Step Verifica...
Gay Hate Crimes In NYC
Gay Hate Crimes In NYC              
Dumpster Diver Seeks Cans, Gets Python
Dumpster Diver Seeks Cans, Gets Pyt...


Sign-in
Existing NASDAQ.com member? Log in here.

By signing into to the site using any of the third-party services above, you agree to NASDAQ.com's Terms of Use.

From Our Trusted News Source





Most Active by Volume:

Company Last Sale Change Net / %
BAC $ 13.31 0.13  0.97%
PFE $ 29.30 0.52  1.81%
GE $ 23.86 0.20  0.85%
F $ 14.97 0.02  0.13%
MSFT $ 34.61 0.24  0.69%
QQQ $ 73.65 0.62  0.83%
MU $ 10.92 0.31  2.76%
INTC $ 24.07 0.08  0.33%